Management of Postoperative Urinary Retention
Discontinue diphenhydramine immediately as it is the most likely cause of this patient's urinary retention due to its anticholinergic properties.
Understanding the Current Situation
This 53-year-old man is experiencing urinary retention on postoperative day 3 following hip arthroplasty revision. The patient has:
- Suprapubic fullness on examination
- 660 mL of urine drained via catheter
- Recently discontinued oxycodone
- Currently taking diphenhydramine at bedtime
- Other medications include ramipril and amlodipine
Causative Factors Analysis
Medication-Related Causes
Diphenhydramine (primary cause):
- First-generation antihistamine with significant anticholinergic properties
- Directly causes urinary retention through muscarinic receptor blockade 1, 2
- Listed in the American Geriatrics Society guidelines as a medication that should be avoided in older adults due to its anticholinergic effects, including urinary retention 1
- FDA labeling specifically warns about urinary retention, especially in patients with prostatic enlargement 2
Recently discontinued opioids:
- Opioids can cause urinary retention but the patient is no longer taking oxycodone
- The residual effects may have contributed initially but are unlikely to be the primary ongoing cause
Other Contributing Factors
- Male sex (higher risk for urinary retention)
- Recent surgery (pelvic area procedures increase risk)
- Postoperative status (altered mobility and positioning)
Management Algorithm
First step: Discontinue diphenhydramine 1, 3
- The anticholinergic properties directly contribute to urinary retention
- The American Geriatrics Society specifically recommends avoiding medications with anticholinergic properties like diphenhydramine to prevent delirium and other complications 1
Catheter management:
- Remove the catheter within 24 hours if possible to reduce infection risk 3
- Monitor for successful voiding within 6-8 hours after catheter removal
If urinary retention persists after diphenhydramine discontinuation:
Evidence-Based Rationale
The Mayo Clinic Proceedings guideline on polypharmacy management specifically identifies diphenhydramine as a high-risk medication in older adults that can cause "CNS impairment: delirium, slowed comprehension; impairs vision, urine retention, constipation, sedating, falling" 1.
Diphenhydramine has strong anticholinergic properties that directly affect bladder function by inhibiting detrusor muscle contraction and promoting urinary retention 3, 2. According to the American Geriatrics Society guidelines, anticholinergic medications like diphenhydramine should be avoided postoperatively in older adults to prevent complications including urinary retention 1.
Monitoring After Intervention
- Assess for successful voiding after diphenhydramine discontinuation
- Monitor for signs of urinary tract infection
- Consider alternative sleep aids if insomnia persists (non-anticholinergic options)
- If retention persists despite diphenhydramine discontinuation, consider urologic consultation
Common Pitfalls to Avoid
- Obtaining unnecessary urine culture - Not indicated in this case as the urinalysis is bland and there are no signs of infection
- Continuing diphenhydramine - This would perpetuate the urinary retention
- Premature alpha-blocker therapy - While tamsulosin may be beneficial if retention persists, the first step should be removing the causative agent (diphenhydramine)
- Failure to recognize medication-induced causes - Always review the medication list when evaluating urinary retention
By discontinuing diphenhydramine, you address the most likely cause of this patient's urinary retention while avoiding unnecessary testing or interventions.